Report Detail
Global T-cell Bispecific Antibodies Drug Market Research Report 2022
- RnM4439971 |
- 16 May, 2022 |
- Global |
- 67 Pages |
- QYResearch |
- Pharma & Healthcare
Summary:
Bispecific T-cell engager (BiTE) stands out as a novel subclass of T-cell engaging bsAbs with promising clinical results in the treatment of cancers.
Industry Insights
Due to the COVID-19 pandemic, the global T-cell Bispecific Antibodies Drug market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe T-cell Bispecific Antibodies Drug market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe T-cell Bispecific Antibodies Drug landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
Blincyto accounting for % of the T-cell Bispecific Antibodies Drug global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hematological Cancers segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.
The global major manufacturers of T-cell Bispecific Antibodies Drug include Amgen and Immunocore etc. In terms of revenue, the global 3 largest players have a % market share of T-cell Bispecific Antibodies Drug in 2021.
This report focuses on T-cell Bispecific Antibodies Drug volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall T-cell Bispecific Antibodies Drug market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Post-covid-19 Outlook
The readers in the section will understand how the T-cell Bispecific Antibodies Drug market scenario changed across the globe during the pandemic and post-pandemic. The study is done keeping in view the changes in aspects such as sales, demand and supply chain. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Segmental Outlook
Key segments including type and application have been elaborated in this report. The consultants at QY Research have studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and application during the historical period (2017-2022) and forecast period (2023-2028).
Segment by Type
Blincyto
Kimmtrak
Segment by Application
Hematological Cancers
Solid Tumors
Regional Outlook
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028. This information derived through comprehensive research will help the reader to get familiar with the potential value of the investment in a particular region.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Competitive Scenario
In this section, the readers will gain an understanding of the key players competing. The experts at QY Research have studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
Amgen
Immunocore
Frequently Asked Questions
Which product segment grabbed the largest share in the T-cell Bispecific Antibodies Drug market?
How is the competitive scenario of the T-cell Bispecific Antibodies Drug market?
Which are the key factors aiding the T-cell Bispecific Antibodies Drug market growth?
Which are the prominent players in the T-cell Bispecific Antibodies Drug market?
Which region holds the maximum share in the T-cell Bispecific Antibodies Drug market?
What will be the CAGR of the T-cell Bispecific Antibodies Drug market during the forecast period?
Which application segment emerged as the leading segment in the T-cell Bispecific Antibodies Drug market?
What key trends are likely to emerge in the T-cell Bispecific Antibodies Drug market in the coming years?
What will be the T-cell Bispecific Antibodies Drug market size by 2028?
Which company held the largest share in the T-cell Bispecific Antibodies Drug market?
Table of Contents
1 T-cell Bispecific Antibodies Drug Market Overview
- 1.1 Product Overview and Scope of T-cell Bispecific Antibodies Drug
- 1.2 T-cell Bispecific Antibodies Drug Segment by Type
- 1.2.1 Global T-cell Bispecific Antibodies Drug Sales Growth Rate Comparison by Type (2022-2028)
- 1.2.2 Blincyto
- 1.2.3 Kimmtrak
- 1.3 T-cell Bispecific Antibodies Drug Segment by Application
- 1.3.1 Global T-cell Bispecific Antibodies Drug Sales Comparison by Application: (2022-2028)
- 1.3.2 Hematological Cancers
- 1.3.3 Solid Tumors
- 1.4 Global T-cell Bispecific Antibodies Drug Market Size Estimates and Forecasts
- 1.4.1 Global T-cell Bispecific Antibodies Drug Revenue 2017-2028
- 1.4.2 Global T-cell Bispecific Antibodies Drug Sales 2017-2028
- 1.4.3 T-cell Bispecific Antibodies Drug Market Size by Region: 2017 Versus 2021 Versus 2028
2 T-cell Bispecific Antibodies Drug Market Competition by Manufacturers
- 2.1 Global T-cell Bispecific Antibodies Drug Sales Market Share by Manufacturers (2017-2022)
- 2.2 Global T-cell Bispecific Antibodies Drug Revenue Market Share by Manufacturers (2017-2022)
- 2.3 Global T-cell Bispecific Antibodies Drug Average Price by Manufacturers (2017-2022)
- 2.4 Manufacturers T-cell Bispecific Antibodies Drug Manufacturing Sites, Area Served, Product Type
- 2.5 T-cell Bispecific Antibodies Drug Market Competitive Situation and Trends
- 2.5.1 T-cell Bispecific Antibodies Drug Market Concentration Rate
- 2.5.2 The Global Top 5 and Top 10 Largest T-cell Bispecific Antibodies Drug Players Market Share by Revenue
- 2.5.3 Global T-cell Bispecific Antibodies Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 T-cell Bispecific Antibodies Drug Retrospective Market Scenario by Region
- 3.1 Global T-cell Bispecific Antibodies Drug Retrospective Market Scenario in Sales by Region: 2017-2022
- 3.2 Global T-cell Bispecific Antibodies Drug Retrospective Market Scenario in Revenue by Region: 2017-2022
- 3.3 North America T-cell Bispecific Antibodies Drug Market Facts & Figures by Country
- 3.3.1 North America T-cell Bispecific Antibodies Drug Sales by Country
- 3.3.2 North America T-cell Bispecific Antibodies Drug Revenue by Country
- 3.3.3 United States
- 3.3.4 Canada
- 3.4 Europe T-cell Bispecific Antibodies Drug Market Facts & Figures by Country
- 3.4.1 Europe T-cell Bispecific Antibodies Drug Sales by Country
- 3.4.2 Europe T-cell Bispecific Antibodies Drug Revenue by Country
- 3.4.3 Germany
- 3.4.4 France
- 3.4.5 U.K.
- 3.4.6 Italy
- 3.4.7 Russia
- 3.5 Asia Pacific T-cell Bispecific Antibodies Drug Market Facts & Figures by Region
- 3.5.1 Asia Pacific T-cell Bispecific Antibodies Drug Sales by Region
- 3.5.2 Asia Pacific T-cell Bispecific Antibodies Drug Revenue by Region
- 3.5.3 China
- 3.5.4 Japan
- 3.5.5 South Korea
- 3.5.6 India
- 3.5.7 Australia
- 3.5.8 China Taiwan
- 3.5.9 Indonesia
- 3.5.10 Thailand
- 3.5.11 Malaysia
- 3.6 Latin America T-cell Bispecific Antibodies Drug Market Facts & Figures by Country
- 3.6.1 Latin America T-cell Bispecific Antibodies Drug Sales by Country
- 3.6.2 Latin America T-cell Bispecific Antibodies Drug Revenue by Country
- 3.6.3 Mexico
- 3.6.4 Brazil
- 3.6.5 Argentina
- 3.7 Middle East and Africa T-cell Bispecific Antibodies Drug Market Facts & Figures by Country
- 3.7.1 Middle East and Africa T-cell Bispecific Antibodies Drug Sales by Country
- 3.7.2 Middle East and Africa T-cell Bispecific Antibodies Drug Revenue by Country
- 3.7.3 Turkey
- 3.7.4 Saudi Arabia
- 3.7.5 UAE
4 Global T-cell Bispecific Antibodies Drug Historic Market Analysis by Type
- 4.1 Global T-cell Bispecific Antibodies Drug Sales Market Share by Type (2017-2022)
- 4.2 Global T-cell Bispecific Antibodies Drug Revenue Market Share by Type (2017-2022)
- 4.3 Global T-cell Bispecific Antibodies Drug Price by Type (2017-2022)
5 Global T-cell Bispecific Antibodies Drug Historic Market Analysis by Application
- 5.1 Global T-cell Bispecific Antibodies Drug Sales Market Share by Application (2017-2022)
- 5.2 Global T-cell Bispecific Antibodies Drug Revenue Market Share by Application (2017-2022)
- 5.3 Global T-cell Bispecific Antibodies Drug Price by Application (2017-2022)
6 Key Companies Profiled
- 6.1 Amgen
- 6.1.1 Amgen Corporation Information
- 6.1.2 Amgen Description and Business Overview
- 6.1.3 Amgen T-cell Bispecific Antibodies Drug Sales, Revenue and Gross Margin (2017-2022)
- 6.1.4 Amgen T-cell Bispecific Antibodies Drug Product Portfolio
- 6.1.5 Amgen Recent Developments/Updates
- 6.2 Immunocore
- 6.2.1 Immunocore Corporation Information
- 6.2.2 Immunocore Description and Business Overview
- 6.2.3 Immunocore T-cell Bispecific Antibodies Drug Sales, Revenue and Gross Margin (2017-2022)
- 6.2.4 Immunocore T-cell Bispecific Antibodies Drug Product Portfolio
- 6.2.5 Immunocore Recent Developments/Updates
7 T-cell Bispecific Antibodies Drug Manufacturing Cost Analysis
- 7.1 T-cell Bispecific Antibodies Drug Key Raw Materials Analysis
- 7.1.1 Key Raw Materials
- 7.1.2 Key Suppliers of Raw Materials
- 7.2 Proportion of Manufacturing Cost Structure
- 7.3 Manufacturing Process Analysis of T-cell Bispecific Antibodies Drug
- 7.4 T-cell Bispecific Antibodies Drug Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
- 8.1 Marketing Channel
- 8.2 T-cell Bispecific Antibodies Drug Distributors List
- 8.3 T-cell Bispecific Antibodies Drug Customers
9 T-cell Bispecific Antibodies Drug Market Dynamics
- 9.1 T-cell Bispecific Antibodies Drug Industry Trends
- 9.2 T-cell Bispecific Antibodies Drug Market Drivers
- 9.3 T-cell Bispecific Antibodies Drug Market Challenges
- 9.4 T-cell Bispecific Antibodies Drug Market Restraints
10 Global Market Forecast
- 10.1 T-cell Bispecific Antibodies Drug Market Estimates and Projections by Type
- 10.1.1 Global Forecasted Sales of T-cell Bispecific Antibodies Drug by Type (2023-2028)
- 10.1.2 Global Forecasted Revenue of T-cell Bispecific Antibodies Drug by Type (2023-2028)
- 10.2 T-cell Bispecific Antibodies Drug Market Estimates and Projections by Application
- 10.2.1 Global Forecasted Sales of T-cell Bispecific Antibodies Drug by Application (2023-2028)
- 10.2.2 Global Forecasted Revenue of T-cell Bispecific Antibodies Drug by Application (2023-2028)
- 10.3 T-cell Bispecific Antibodies Drug Market Estimates and Projections by Region
- 10.3.1 Global Forecasted Sales of T-cell Bispecific Antibodies Drug by Region (2023-2028)
- 10.3.2 Global Forecasted Revenue of T-cell Bispecific Antibodies Drug by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
- 12.1 Methodology/Research Approach
- 12.1.1 Research Programs/Design
- 12.1.2 Market Size Estimation
- 12.1.3 Market Breakdown and Data Triangulation
- 12.2 Data Source
- 12.2.1 Secondary Sources
- 12.2.2 Primary Sources
- 12.3 Author List
Summary:
Get latest Market Research Reports on T-cell Bispecific Antibodies Drug. Industry analysis & Market Report on T-cell Bispecific Antibodies Drug is a syndicated market report, published as Global T-cell Bispecific Antibodies Drug Market Research Report 2022. It is complete Research Study and Industry Analysis of T-cell Bispecific Antibodies Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
